ZELLENPENETRIERENDE PEPTIDE
European patent · EP2797616 · In force
Register entry
- Publication number
- EP2797616
- Application number
- EP12813376
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Dec 27, 2012
- Published
- Nov 5, 2014
- Granted
- Jul 31, 2019
- Protection ends at the latest
- Dec 26, 2032
- Next annual fee due
- Dec 31, 2026
- IPC classes
- A61K 38/17 (2006.01)C07K 14/47 (2006.01)C07K 19/00 (2006.01)C12N 9/16 (2006.01)
- Priority
- EP 11306784 27.12.2011
- PCT application
- PCT/EP2012/076968 27.12.2012
- PCT publication
- WO2013/098337 04.07.2013
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jan 8, 2026
Change
Published in Swissreg on 08.01.2026
- Jan 9, 2025
Change
Published in Swissreg on 09.01.2025
- Jan 1, 2024
Change
Published in Swissreg on 01.01.2024
- May 8, 2023
Address changed
- Representative
- Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel → VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 08.05.2023
- Jan 1, 2023
Change
Published in Swissreg on 01.01.2023
- Oct 16, 2019
Agent entered
- Representative
- Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel
Published in Swissreg on 16.10.2019
- Jul 31, 2019
Granted
Published in Swissreg on 31.07.2019
Parties
Holder
Inventor
E-28034 Madrid, ES
F-75018 Paris, FR
F-75015 Paris, FR
E-46020 Valencia, ES
F-91370 Verrieres Le Buisson, FR
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.